Utah Medical Products, Inc. Stock

$55.52

0.89%

Nasdaq, Jul 18, 10:00 pm CET

ISIN

US9174881089

Symbol

UTMD

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Utah Medical Products, Inc. Stock price

$55.52

-31.77 36.39% 5Y

Nasdaq, Closing price Fri, Jul 18 2025

-0.50 0.89%

ISIN

US9174881089

Symbol

UTMD

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

$180.3m

Enterprise Value

$97.4m

Net debt

positive

Cash

$83.0m

Shares outstanding

3.3m

Valuation (TTM | estimate)

P/E

13.6 | -

P/S

4.4 | -

EV/Sales

2.4 | -

EV/FCF

6.7

P/B

1.5

Dividends

DPS

$1.21

Yield 1Y | 5Y

2.2% | 1.3%

Growth 1Y | 5Y

1.7% | 2.1%

Payout 1Y | 3Y

30.4% | 27.2%

Increased

3 Years

Financials (TTM | estimate)

Revenue

$40.9m | -

EBITDA

$16.4m | -

EBIT

$13.6m | -

Net Income

$13.9m | -

Free Cash Flow

$14.6m

Growth (TTM | estimate)

Revenue

-18.6% | -

EBITDA

-29.0% | -

EBIT

-19.0% | -

Net Income

-16.6% | -

Free Cash Flow

-32.5%

Financial Health

Equity Ratio

95.8%

Return on Equity

11.8%

ROCE

11.4%

ROIC

Debt/Equity

0.0

EPS

$4.1

FCF per Share

$4.4

Short interest

3.2%

Employees

161

Rev per Employee

$250.0k

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Get Started for Free Today

Utah Medical Products, Inc. Stock Analysis

Unlock Scores for Free

??

Financial data from Utah Medical Products, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	41 41	19% 19% 100%
- Direct Costs	17 17	17% 17% 41%
Gross Profit	24 24	20% 20% 59%
- Selling and Administrative Expenses	9.74 9.74	23% 23% 24%
- Research and Development Expense	0.81 0.81	45% 45% 2%
EBITDA	16 16	29% 29% 40%
- Depreciation and Amortization	2.80 2.80	56% 56% 7%
EBIT (Operating Income) EBIT	14 14	19% 19% 33%
Net Profit	14 14	17% 17% 34%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Utah Medical Products, Inc. Stock News

Positive

Seeking Alpha

●

18 days ago

Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest

I reiterate my strong buy on UTMD, citing its robust balance sheet, disciplined capital allocation, and 43% upside to my $82.22 price target. Revenue headwinds appear to be stabilizing, with legendary value investor Charles Brandes taking a 7.4% stake, signaling renewed institutional interest. Key risks include Filshie Clip litigation, declining China sales, and succession planning, but UTMD's ...

Neutral

Accesswire

●

3 months ago

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / May 6, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on July 3, 2025 to stockholders of record at the close of business on June 16, 2025. This is a 1.7% increase over the dividend declared in the same quarter of...

Positive

Seeking Alpha

●

3 months ago

Stock Picks From Seeking Alpha's April 2025 New Analysts

In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasizing an under-recognized growth driver, discounted valuation, and a substantial margin of safety. Analysts also highlighted Sell recommendations on Estée Lauder and Intuitive Surgical, citing deter...

More Utah Medical Products, Inc. News

Company Profile

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Head office	United States
CEO	Kevin Cornwell
Employees	161
Founded	1978
Website	www.utahmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now